About this episode

The episode features a discussion with Joe Catanese, CEO of Calyxo, about his new urology startup and insights from HistoSonics' CEO Mike Blue on fundraising.

In this episode of the DeviceTalks Weekly Podcast, host Tom Salemi is reassured by his conversation with Joe Catanese, CEO of Calyxo, a urology startup that has developed a system designed to simplify kidney stone removal. Catanese previously helped build Neotract, a urology startup that was acquired by Teleflex for more than $1 billion. Now, he's leading another potential gamechanger and may have his sights set on an IPO. Speaking of gamechangers, HistoSonics continues to shatter fundraising expectations. The company recently completed a financing round that valued it at $3.75 billion. In this week's FOMO interview, HistoSonics President and CEO Mike Blue speaks with MassDevice Editor Chris Newmarker during a keynote conversation at DeviceTalks Minnesota. In this excerpt, Blue reflects on the company's first major fundraising round, which attracted high-profile investors including Jeff Bezos and Peter Thiel, and shares his perspective on just how large the opportunity for histotripsy could become. But first, Tom and Jim Hammerand, managing editor of Medical Design & Outsourcing, discuss AI—or LLMs, or whatever term you prefer. Is the hype beginning to fade? And what should the…

People in this episode

Host: Tom Salemi

Guests: Joe Catanese, Mike Blue

Topics covered

• urology
• startup
• fundraising
• AI
• healthcare
• IPO

Keywords

• Calyxo
• Joe Catanese
• HistoSonics
• fundraising
• urology
• AI
• IPO

Mentioned in this episode

Organizations: Calyxo, Neotract, Teleflex, HistoSonics, MassDevice, DeviceTalks, Midjourney Medical, Medical Design & Outsourcing

Places: Minnesota

More episodes of DeviceTalks Podcast Network

• J&J MedTech’s Devi Govender wants to change the lives – and the language – of heart recovery patients · July 17, 2026 · 1h 18m
• XCATH’s Eduardo Fonseca on Building a Mission Driven Culture Behind a Robotic Stroke Revolution · July 10, 2026 · 1h 11m
• Reeve Stoffer Explains Why a Reset Might Have Been the Best Thing for Recor Medical and Renal Denervation · June 19, 2026 · 1h 2m

Explore listener stats, chart rankings, contacts and more on the DeviceTalks Podcast Network podcast page.